FWBI Stock Earnings: First Wave BioPharma Reported Results for Q1 2023
Source: iQoncept / Shutterstock
First Wave BioPharma (NASDAQ:FWBI) just reported results for the first quarter of 2023.
- First Wave BioPharma reported earnings per share of -$36.40.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/fwbi-stock-earnings-first-wave-biopharma-for-q1-of-2023/.
©2023 InvestorPlace Media, LLC